Finally had to come. At least the science keeps moving on while the CEO screws the retailers on CRs.
- Forums
- ASX - By Stock
- Ann: Phase 2 blood cancer trial fully recruited
Finally had to come. At least the science keeps moving on while...
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.002(4.88%) |
Mkt cap ! $53.55M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 3.9¢ | $69.92K | 1.738M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 333839 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 210000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 333839 | 0.039 |
4 | 326707 | 0.038 |
1 | 300000 | 0.037 |
2 | 583000 | 0.036 |
5 | 514100 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 210000 | 2 |
0.042 | 100000 | 1 |
0.043 | 200000 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 13.48pm 12/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online